Implantable medical device crosstalk evaluation and mitigation

US9775987B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9775987-B2
Application numberUS-36279209-A
CountryUS
Kind codeB2
Filing dateJan 30, 2009
Priority dateOct 31, 2008
Publication dateOct 3, 2017
Grant dateOct 3, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Electrical crosstalk between two implantable medical devices or two different therapy modules of a common implantable medical device may be evaluated, and, in some examples, mitigated. In some examples, one of the implantable medical devices or therapy modules delivers electrical stimulation to a nonmyocardial tissue site or a nonvascular cardiac tissue site, and the other implantable medical device or therapy module delivers cardiac rhythm management therapy to a heart of the patient.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method comprising: determining a noise characteristic of a first electrical signal sensed by a first implantable medical device (IMD) while a second IMD is delivering a second electrical signal to a tissue site within a patient, wherein the first and second IMDs are implanted within the patient; comparing the noise characteristic of the first electrical signal to a threshold value, wherein comparing the noise characteristic to the threshold value comprises determining whether the noise characteristic is greater than or equal to the threshold value; and in response to determining the noise characteristic of the first electrical signal is greater than or equal to the threshold value, modifying at least one of a stimulation parameter with which the second IMD generates electrical stimulation that is delivered to the tissue site or a sensing parameter with which the first IMD senses the first electrical signal based on the comparison. 2. The method of claim 1 , wherein the tissue site comprises at least one of a nonmyocardial tissue site or a nonvascular cardiac tissue site. 3. The method of claim 1 , wherein the tissue site comprises at least one of an extravascular tissue site or the tissue site proximate to a nerve of the patient. 4. The method of claim 1 , wherein the first implantable medical device delivers at least one of pacing, cardioversion or defibrillation therapy to a heart of the patient. 5. The method of claim 1 , wherein the second implantable medical device delivers at least one of pacing, cardioversion or defibrillation therapy to the tissue site. 6. The method of claim 1 , wherein determining the noise characteristic of the first electrical signal comprises determining a value indicative of a difference between an amplitude of the first electrical signal and a sensing threshold of the first implantable medical device. 7. The method of claim 1 , wherein determining the noise characteristic of the first electrical signal comprises: suspending delivery of the second electrical signal by the second implantable medical device (IMD); sensing a third electrical signal with the first IMD; activating the delivery of the second electrical signal by the second IMD; sensing the first electrical signal with the first IMD while second IMD delivers the second electrical signal to the tissue site; and determining a difference between at least one signal characteristic of the first and third electrical signals. 8. The method of claim 7 , wherein determining the difference between at least one signal characteristic of the first and third electrical signals comprises: determining a first value indicative of a difference between a first amplitude of the first electrical signal and a sensing threshold of the first implantable medical device (IMD); determining a second value indicative of a difference between a second amplitude of the third electrical signal and the sensing threshold of the first IMD; and determining the difference between the first and second values. 9. The method of claim 8 , wherein comparing the noise characteristic of the first electrical signal to the threshold value comprises determining whether the difference between the first and second values is greater than or equal to the threshold value. 10. The method of claim 9 , wherein the threshold value is less than the sensing threshold of the first implantable medical device. 11. The method of claim 10 , wherein the threshold value is about 25 percent (%) to about 50% of the sensing threshold of the first implantable medical device. 12. The method of claim 7 , wherein determining the difference between at least one signal characteristic of the first and third electrical signals comprises determining the difference between at least one signal characteristic of the first and third electrical signals during a quiet segment of a cardiac cycle of a heart of the patient. 13. The method of claim 7 , wherein determining the difference between at least one signal characteristic of the first and third electrical signals comprises determining a difference between one or more frequency band characteristics of the first and third electrical signals. 14. The method of claim 1 , wherein determining the noise characteristic of the first electrical signal comprises determining a first characteristic of the first electrical signal sensed by the first implantable medical device (IMD) at a first time and modifying the at least one of the stimulation parameter or the sensing parameter comprises modifying at least one stimulation parameter, the method further comprising: delivering a third electrical signal to the tissue site via the second IMD according to the at least one modified stimulation parameter; determining a second characteristic of a fourth electrical signal sensed by the first IMD at a second time while the second IMD is delivering the third electrical signal; and determining an electrical noise status based on the second characteristic. 15. The method of claim 14 , wherein modifying the stimulation parameter comprises modifying a first value of a first stimulation parameter and determining the electrical noise status based on the second characteristic comprises comparing the second characteristic to the threshold value, the method further comprising modifying a second value of a second stimulation parameter with which the second implantable medical device generates the electrical stimulation in response to determining the second characteristic is greater than or equal to the threshold value, wherein the first and second stimulation parameters are different. 16. The method of claim 14 , wherein determining the electrical noise status based on the second characteristic comprises comparing the second characteristic to the threshold value, the method further comprising modifying the at least one stimulation parameter in response to determining the second characteristic is greater than or equal to the threshold value. 17. The method of claim 14 , wherein determining the electrical noise status based on the second characteristic comprises comparing the second characteristic to the threshold value, the method further comprising adjusting the delivery of electrical stimulation by the second implantable medical device in response to determining the second characteristic is greater than or equal to the threshold value. 18. The method of claim 17 , wherein adjusting the delivery of electrical stimulation by the second implantable medical device (IMD) comprises suspending the delivery of electrical stimulation by the second IMD. 19. The method of claim 1 , further comprising generating and storing an interference indication in response to determining the noise characteristic is greater than or equal to the threshold value. 20. The method of claim 1 , wherein the stimulation parameter comprises at least one of a current amplitude, a voltage amplitude, a pulse width, a pulse rate, a frequency, a duty cycle or an electrode combination. 21. The method of claim 1 , wherein the sensing parameter comprises at least one of a sensing threshold value, an amplifier gain, a sensing vector, filter characteristic, or a type of physiological parameter of the patient that is sensed by the first implantable medical device. 22. The method of claim 21 , wherein the filter characteristic comprises a type of filter applied by the first implantable medical device to the sensed first electrical signal.

Assignees

Inventors

Classifications

  • in combination with another heart therapy · CPC title

  • Cardiac control, e.g. by vagal stimulation (stimulating the heart A61N1/362) · CPC title

  • A61N1/0551Primary

    Spinal or peripheral nerve electrodes · CPC title

  • characterised by communication with experts in remote locations using a network · CPC title

  • for treating or preventing abnormally high heart rate · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9775987B2 cover?
Electrical crosstalk between two implantable medical devices or two different therapy modules of a common implantable medical device may be evaluated, and, in some examples, mitigated. In some examples, one of the implantable medical devices or therapy modules delivers electrical stimulation to a nonmyocardial tissue site or a nonvascular cardiac tissue site, and the other implantable medical d…
Who is the assignee on this patent?
Donofrio William T, Burnes John E, Krause Paul G, and 6 more
What technology area does this patent fall under?
Primary CPC classification A61N1/0551. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Oct 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).